QuadraMed names new chairman

Michael Bassett | | Health Imaging | Artificial Intelligence
QuadraMed has named James E. Peebles chairman of its board of directors, replacing Robert Pevenstein, who has served as chairman for the last three and one-half years.

Peebles' move into the chairmanship follows closely on the heels of the appointment of Duncan James to be CEO of the the Reston-Va.-based health IT developer.

“Bob Pevenstein has done an outstanding job, and I will continue to rely heavily on him for guidance and assistance. I am also looking forward to working with Duncan James as I am confident that the expertise and strategy that he brings to the team will continue to strengthen QuadraMed’s prestige in the healthcare industry,” said Peebles.

Pebbles will remain as the chairman of the audit committee.

Michael Bassett,

Contributor

Related Content

AI reduces CT lung cancer screening workload by nearly 80%
How AI and CCTA help heart teams plan ahead before PCI
5 steps for evaluating radiology AI applications
Adaptable AI system detects subtle changes in imaging, has potential across multiple clinical settings
New algorithm models radiologists' eye movements to interpret chest X-rays
Embracing the future: James Min left academia to push for a paradigm shift in preventive cardiology

Around the web

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

Cardiovascular Business
Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.